Technologies that allow autonomous robots and computer systems to quickly recognize and interact with individuals in a group setting has the potential to enable a wide range of personalized experiences. However, existing solutions fail to both identify and locate individuals with enough speed to enable seamless interactions in very dynamic environments that require fast, implicit, non-intrusive, and ubiquitous recognition of users. In this work, we present a hybrid computer vision and RFID system that uses a novel reverse synthetic aperture technique to recover the relative motion paths of an RFID tags worn by people and correlate that to physical motion paths of individuals as measured with a 3D depth camera. Results show that our real-time system is capable of simultaneously recognizing and correctly assigning IDs to individuals within 4 seconds with 96.6% accuracy and groups of five people in 7 seconds with 95% accuracy. In order to test the effectiveness of this approach in realistic scenarios, groups of five participants play an interactive quiz game with an autonomous robot, resulting in an ID assignment accuracy of 93.3%.

BACKGROUND: Supporting clinical decision support for personalized medicine will require linking genome and phenome variants to a patient's electronic health record (EHR), at times on a vast scale. Clinico-genomic data standards will be needed to unify how genomic variant data are accessed from different sequencing systems. METHODS: A specification for the basis of a clinic-genomic standard, building upon the current Health Level Seven International Fast Healthcare Interoperability Resources (FHIR®) standard, was developed. An FHIR application protocol interface (API) layer was attached to proprietary sequencing platforms and EHRs in order to expose gene variant data for presentation to the end-user. Three representative apps based on the SMART platform were built to test end-to-end feasibility, including integration of genomic and clinical data. RESULTS: Successful design, deployment, and use of the API was demonstrated and adopted by HL7 Clinical Genomics Workgroup. Feasibility was shown through development of three apps by various types of users with background levels and locations. CONCLUSION: This prototyping work suggests that an entirely data (and web) standards-based approach could prove both effective and efficient for advancing personalized medicine.